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Background. Meditation practices are associated with a reduction in adrenergic activity that may benefit patients with severe cardiac
arrhythmias. This paper describes the design and methods of a pilot study testing the feasibility of a phone-delivered mindfulness-
based intervention (MBI) for treatment of anxiety in patients with implantable cardioverter defibrillators (ICDs). Design and
Methods. Consecutive, clinically stable outpatients (n = 52) will be screened for study eligibility within a month of an ICD-
related procedure or ICD shock and will be randomly assigned to MBI or to usual care. MBI patients will receive eight weekly
individual phone sessions based on two mindfulness practices (awareness of breath and body scan) plus home practice with a
CD for 20 minutes daily. Patients assigned to usual care will be oﬀered the standard care planned by the hospital. Assessments
will occur at baseline and at the completion of the intervention (between 9 and 12 weeks after randomization). The primary
study outcome is feasibility; secondary outcomes include anxiety, mindfulness, and number of administered shocks during the
intervention period. Conclusions. If proven feasible and eﬀective, phone-delivered mindfulness-based interventions could improve
psychological distress in ICD outpatients with serious cardiovascular conditions.
1. Introduction
Sound evidence supports the value of meditation-based
interventions in patients with cardiovascular disease. As far
back as 1971, Wallace et al. [1] described the physiological
characteristics of the “relaxation response” associated with
meditative practices. These included a general decrease in
sympathetic nervous system (SNS) activity, oxygen con-
sumption, and blood lactate levels. Later studies comparing
subjects practicing meditation with nonpractitioners found
reduced endorgan sensitivity to catecholamines, possibly
mediated by a lower percentage of functional lymphocyte
beta-adrenergic receptors [2]. This overall reduction in
the SNS activity may be beneficial in patients aﬀected by
cardiovascular disease as suggested by a number of studies
of transcendental meditation [3–8]. Fewer studies, however,
have explored the possible eﬀect of mindfulness meditation
interventions in this population [9–11].
The most widely available mindfulness training course
is the mindfulness-based stress reduction (MBSR) program
[12] created in the early eighties by Jon Kabat-Zinn. MBSR
oﬀers training in traditional mindfulness meditation adapted
to a non-Buddhist, clinical context. While MBSR has shown
positive results in a wide range of medical and psychological
conditions, including anxiety and depression [13, 14] some
features of the program, such as the need to attend eight
weekly classes and the recommended duration of daily home
mindfulness practice (usually 45 minutes), may constitute
a barrier to participation for patients with severe chronic
cardiovascular disease.
With this study, we sought to evaluate whether a new
delivery method (phone delivery) would overcome some
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of the above-mentioned barriers to mindfulness training in
patients with implantable cardioverter defibrillators (ICDs).
This is a population with severe underlying cardiac condi-
tions and considerable prevalence of psychological distress,
with figures reaching up to 38% for clinically significant anx-
iety and depression [15, 16] for which mindfulness training
may be beneficial. We describe here the design and methods
of a pilot randomized clinical trial examining the feasibility
of a mindfulness-based, phone-delivered intervention in a
group of ICD patients Secondary outcomes will include the
preliminary estimation of eﬃcacy of the intervention on
anxiety and mindfulness scores.
2. Design and Methods
The “Coping with ICD study” (Clinicaltrials.gov NCT01035
294) is a pilot randomized clinical trial designed to evaluate
the feasibility of a phone-administered, mindfulness-based
training program for the treatment of psychological distress
in patients undergoing an ICD procedure, or reporting an
ICD-related event (shocks).
2.1. Setting. The study will be conducted at the university
campus of the UMassMemorial Medical Center (UMMMC),
a tertiary care medical center located in Worcester, MA
admitting more than 300 patients every year for ICD
procedures.
2.2. Recruitment and Screening Procedures. Patients sched-
uled for an ICD-related procedure or who recently had
an ICD-related event (shocks) will be screened for study
eligibility within a month of the procedure/event. All
potentially eligible patients will receive a letter inviting them
to participate and asking them to call a dedicated phone
number to communicate their possible interest. To ensure an
unbiased presentation of the study, we developed a script of
the first phone contact call. If the patient expresses interest, a
screening visit will be scheduled.
Patients will be eligible if they meet the following
criteria: age ≥21, ICD-related procedure or recent ICD
shocks, ability to understand and speak English, and access
to a telephone. Patients will be excluded from the study
under the following conditions: inability/unwillingness to
give informed consent, cognitive impairment, New York
Heart Association (NYHA) functional class >III or Canadian
Cardiovascular Society (CCS) angina class III or IV or
otherwise clinically unstable, pending coronary bypass or
heart transplantation, comorbid life threatening conditions,
and ongoing severe depression or psychosis. The Blessed
Orientation Memory and Concentration test [17] will be
used to screen patients for cognitive impairment. Patients
scoring ≥10 will be excluded from the study since mind-
fulness training requires a normal cognitive function and
ability to focus the attention; cognitive impairment would
limit the ability of the subjects to adequately participate
in the intervention. Screening for ongoing depression and
psychosis will be based on DSM criteria of major depressive
disorder or psychosis as documented by the physician in
the most recent medical evaluation. Once eligibility is
confirmed, we will obtain informed consent in person. Since
the study requires access to protected health information
(PHI), a HIPAA authorization will be signed by each study
subject in order to access his or her medical records. After
baseline data collection is completed, participants will be
randomly assigned to the intervention or to the control
group.
2.3. Randomization. The randomization sequence will be
generated using STATA [18] “ralloc” command, which pro-
duces a sequence of group assignments randomly permuted
in blocks of several sizes. Block sizes of 4 and 6 will be used
in this study. A programmer will generate the random allo-
cation sequence and upload the table containing the random
sequence of group assignments to an Access database. Based
on this table, the participant will be automatically assigned
to a group by clicking the “Randomize” button.
2.4. Follow-Up. To maximize retention, patients in both
study arms will receive a weekly phone call inquiring as to
whether they had questions regarding their participation.
When a participant misses an intervention session, he/she
will be immediately contacted. After three missed contacts,
nonresponders will be sent a letter encouraging them to
discuss their status. Participants will not be expected to
stop any of their usual support services, for example,
professional counseling, support groups, or any antianxiety
or antidepressant treatment.
The study protocol and the study materials were
approved by the Committee for the Protection of Human
Subjects at the University of Massachusetts Medical School
(Docket H-13078).
2.5. Mindfulness-Based Intervention (MBI)
2.5.1. Rationale. The study intervention will adapt elements
of the MBSR [12] program (whose standard curriculum
includes participation in eight weekly classes, lasting two
and a half hours; an all-day retreat; practicing mindfulness
and yoga exercises at home for 45 minutes/day) to the
needs of patients with ICDs. Changes will include in person
phone delivery versus in class delivery of the intervention;
shortening of the duration of the training sessions and of the
individual home practice; the exclusion of the all-day retreat
and of yoga exercises.
Several conditions suggested the need for a modification
of the standardMBSR program for ICD patients. (1) Driving
is usually discouraged in ICD patients during the months
immediately following ICD surgery [19] since up to 8% of
patients experience a shock while driving [20]. This circum-
stance would limit attendance at regular MBSR classes. (2)
Psychological distress is higher soon after ICD implantation
[15], and it is important to start the intervention as close
as possible to the ICD procedure to help alleviate symptoms
when they are more intense. Since most MBSR programs are
usually oﬀered at discrete times, it may not be possible for
many ICD patients to receive the intervention when it is most
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Table 1: Characteristics of the study intervention.
Component Duration Objectives/content Strategies/materials
Screening visit 10 minutes
(i) Patient receives general instructions about the intervention by the study manager
(ii) Patient receives study CD player if needed, intervention CD, and mindfulness
diary
Study CD player
Intervention CD
Mindfulness diary
Phone sessions
(8)
30 minutes
(i) Instructor checks on patient ability to practice specific mindfulness technique(s)
taught during previous session(s)
(ii) Instructor inquires about symptoms/side eﬀects
(iii) Instructor guides patient in mindfulness exercise and receives feedback from
patient
(iv) Instructor and patient develop goals for next session
(v) Instructor encourages participant to practice mindfulness technique with help
of study CD (specifies track, 20′every day)
(vi) Instructor arranges next phone session
(vii) Instructor completes intervention checklist
(viii) Instructor reports problems to study manager
Intervention checklist
Digital recorder for
session recording by
the instructor
needed. (3) Physical activity may trigger arrhythmias and
shocks [21], and it is often avoided by patients at this early
stage for fear of ICD discharges. (4) The clinical condition
of this population with severe underlying cardiovascular
disease may limit their ability to attend classes and to practice
mindfulness exercises for longer periods.
2.5.2. Intervention Content. The conceptual background
informing the intervention was guided by the “parsimo-
nious” model recently proposed by Carmody [22]. Briefly,
in this model mindfulness interventions are described as
training in self-regulation of attention and recognition of
the sensations, cognitions, and feelings that comprise daily
experience. In the untrained individual, negative cycles of
associated thoughts, sensations, and feelings are maintained
by attention being absorbed in their content and/ormeaning.
For example, the presentation of a frightening thought
generates an associational cycle in which the thought leads to
unpleasant sensations of constriction. This negative cycle can
begin with a thought, a feeling, or a sensation and is then self-
maintained as long as the subject’s attention remains engaged
with the content of any of its components. In the process
of mindfulness training, the subject learns to notice which
component the attention is directed toward in any given
moment and to choose to keep the attention where it is or
to redirect it to another object, usually an arousal “neutral”
object such as the sensations of breathing.
Consistently with our endeavor of adapting elements of
the MBSR curriculum to meet the needs of ICD patients, the
intervention’s content will be simplified to include two basic
components: (1) the body scan, a technique based on the
cultivation of attention to bodily sensations and cognitions
that would normally go unnoticed and (2) training in the
awareness of the sensations of breathing. In addition, par-
ticipants will be gradually taught to direct their attention to
simple activities of daily life (such as eating and drinking), to
sounds, visual objects, thoughts, and emotions and to recog-
nize when their attention is no longer focused on that specific
object of attention. At the final session, participants will prac-
tice “open awareness” in which they will be instructed to just
notice which events (physical sensation, sound, visual object,
and/or thought) their attention will be spontaneously drawn
to from moment to moment. Patients will not receive addi-
tional materials usually provided to MBSR trainees in the
form of poetry or other readings. In addition, lovingkindness
(“metta” practice—a technique based on deliberately gener-
ating feelings of compassion, benevolence, and acceptance
towards self and others) will not be a component of the study
intervention. This technique was excluded because there is
insuﬃcient evidence for a benefit of such a practice on psy-
chological well-being in patients with cardiovascular disease
and because it would imply a diﬀerent study hypothesis that
deserves to be tested in a separate investigation.
2.5.3. Intervention Format. The study intervention will con-
sist of eight phone-delivered, individual training sessions
each lasting 30 minutes (Table 1). Twenty minutes will
be spent on intervention delivery, and 10 minutes on
questions, answers, and scheduling the next intervention.
At the beginning of the study patients will receive an audio
CD consisting of two diﬀerent mindfulness practices, each
lasting about 20 minutes, consistent with the techniques
learned during each session with the instructor: track 1:
sitting practice; track 2: body scan practice. After the delivery
of the first intervention, participants will be encouraged to
listen to the audio CD every day, at least once a day, and then
throughout the study. The CD can be played using a regular
CD player or a computer, and a portable CD player will be
given to participants when needed.
To ensure that the delivery of the intervention will be
similar across instructors we developed a script of each
session. Although instructors will not have to follow the
script verbatim, they will be expected to follow the sequence
indicated in the script. Figure 1 shows the components of
the intervention, each in a diﬀerent color, and the session at
which it was introduced. By looking at each row in this table
it is possible to identify the content of each individual session.
2.6. Instructors. The instructors will be healthcare profes-
sionals and graduates of the Center for Mindfulness Profes-
sional Training Program with at least five-year experience in
mindfulness training and a personal mindfulness practice.
Prior to the study beginning, they will receive three hours
of training, including a detailed review of the intervention
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Sessions Intervention components
Awareness
of
breath
Mindful 
eating 
exercise
Body scan Mindful 
drinking 
exercise
Awareness 
of sounds
Awareness 
of emotions
Awareness 
of thoughts
Open
awareness
1
2
3
4
5
6
7
8
Figure 1: Overview of the study intervention component by session number. Each color indicates a diﬀerent component of the intervention.
script. We will hold bimonthly meetings to discuss any
questions or diﬃculties that might be arising during the
intervention sessions. Each patient will be trained by the
same instructor throughout the intervention, and although
not blinded to group assignment, instructors will be blinded
to the study outcomes. At the end of each session, the
instructors will complete an attendance form and a checklist
in which duration and delivery of the intervention as
specified in the intervention script as well as their perception
of the patient’s level of engagement during the session
will be recorded. Patient’s engagement will be evaluated
immediately after each session and scored on a scale of 1
(completely unengaged) to 10 (extremely engaged). In order
to monitor the provider’s adherence to the protocol and
the consistency of the delivery of the intervention across
providers, each session will be digitally recorded by the
instructor. Electronic copies of the attendance form, the
checklist, and the MP3 file of the recorded session will be
emailed weekly to the study manager.
2.7. Control Group: Usual Care (UC). Patients in the control
group will receive the usual care provided by UMMMC to
all ICD patients. Due to budgetary constraints, it was not
possible to use an active control condition. To oﬀset this
limitation at least partially, patients in the usual care arm will
receive a weekly phone call (duration: 5–10 minutes) that,
although not designed to oﬀer a specific intervention, will
be aimed at addressing patients’ possible concerns regarding
their health or the ICD. If such concerns presented, the
patient will be advised to contact his/her physician or nurse
at the electrophysiology clinic. This phone call will also help
to equalize the amount of study contact between study arms.
2.8. Study Assessments. Data collection will be performed at
the baseline interview immediately after consent is provided,
and nine weeks after enrollment once the intervention is
completed.
2.8.1. Primary Outcome: Feasibility. Feasibility metrics in-
clude eligibility and recruitment rates, retention rates, inter-
vention adherence rates, treatment fidelity, and patient’s
experience with the intervention. Recruitment metrics
include number of screened and eligible patients, number of
eligible patients who refused to participate, and reasons for
refusal. Retention measures will be the number of subjects
who dropped out or were lost to followup and reason(s) for
dropping out. Adherence metrics include number of sessions
attended and total time spent in mindfulness practice in
hours over the intervention period. In addition, the time
spent engaging in each separate technique will be collected.
Mindfulness practice will be self-reported by means of a
daily diary that patients will receive at the consenting visit,
and will be instructed to mail them back using prestamped
envelopes. A similar diary was successfully used in a study
[23] of the eﬀect of mindfulness training on hot flashes in
menopausal women. Treatment fidelity (developed following
Treatment Fidelity Workgroup guidelines) [24] will be both
self-reported by the instructors (by means of a checklist to
be completed at the end of each session) and objectively
evaluated by reviewing a random sample (10%) of all
recorded sessions, and will be defined as the average of the
ratio between the number of objectives achieved versus the
number of objectives planned for each session, multiplied by
100, calculated from the checklist form.
2.8.2. Secondary Outcomes
Mindfulness. Baseline and postintervention mindfulness
scores will be measured using the Five Facets of Mindfulness
(FFM) questionnaire [25], an instrument derived from a
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Table 2: Sample size calculations§.
Measure Instrument Definition
Hypothesized mean
(SD) control group
Hypothesized mean
(SD) intervention group
Sample
size (total)
Anxiety HADS
Mean diﬀerences between baseline
and postintervention
3.0 (2.2) 5.1 (2.6) 42
§
Null hypothesis Ho = mean diﬀerence in pre- /post-HADS score in intervention group = mean diﬀerence in pre- /post-HADS score in control group; α
(two-tailed) = 0.05 and 1−β = 0.8.
factor analysis of questionnaires measuring mindfulness in
daily life. It consists of 39 items, exploring diﬀerent aspects
of mindfulness: observing, describing, acting with awareness,
nonjudging of inner experience, and nonreactivity to inner
experience. Each item is rated on a Likert scale ranging from
1 (never or very rarely true) to 5 (very often or always true).
The FFM has shown good internal consistency [25].
Anxiety. Anxiety will be measured using the Hospital Anx-
iety and Depression Scale, [26] a 14-item self-administered
questionnaire with two subscales measuring anxiety and
depression, with higher scores indicating greater psycholog-
ical morbidity. A cutoﬀ point of 8 is usually recommended
to screen patients for clinically significant depression and
anxiety [26–28]. A correlation between 0.6 and 0.8 has
been reported between the HADS and other commonly
used questionnaires for anxiety and depression such as
the Beck Depression Inventory and the State-Trait Anxiety
Inventory [27], and its validity has been confirmed both
in hospital settings and primary care medical practice [29].
Furthermore, the HADS oﬀers the advantage of focusing on
cognitive symptoms of anxiety instead of physical symptoms;
this is particularly useful in cardiac patients where symptoms
of the underlying cardiac disease may be similar or identical
to those resulting from somatic manifestations of anxiety.
Number of Shocks. The number of delivered shocks (if any)
will be abstracted from the electronic version of the follow-
up visit 9 weeks after enrollment. While patients can receive
care in other centers during the follow-up period, ICD-
specific follow-up visits are mostly performed at UMMMC,
thus limiting the chance of missing important information
about ICD functioning and arrhythmic events.
Covariates. Information will be collected on demograph-
ics (age, gender, ethnicity, education, marital status, and
financial status), type of ICD, indication for and time from
the ICD procedure or shocks, prior history of anxiety and
depression, ejection fraction and cardiac functional status,
hospital readmissions during the study period, ongoing
medications as well as other relevant data such as physical
activity, use of other complementary medicine treatments,
and life events (i.e., death or illness of spouse or relative)
during the study period.
2.9. Data Sources. Demographic data, physical activity, use
of other complementary/alternative therapies, anxiety, and
mindfulness scores will be obtained from self-administered
standardized questionnaires. Medical history, including past
history of anxiety or depression, prescription of psy-
chotropic medications and antiarrhythmic drugs, indica-
tion for ICD implantation, functional class, and number
of shocks/arrhythmic episodes and hospital readmissions
will be abstracted directly from the medical record. Study
questionnaires will be administered by in-person interview
at baseline and by phone interview at week 9. Questionnaires
delivery via phone interview (following intervention) was
preferred to mailing of questionnaires because response rates
tend to be higher using the telephone as compared with
mailed surveys [30]. Furthermore, the study population will
likely include older individuals who may have diﬃculties
reading the surveys. There is evidence that for some people,
particularly those of low literacy and education, telephone
interview is less intimidating.
2.10. Data Management. Daily management of study activ-
ities will be facilitated by the use of Microsoft Access 2007
tracking system software. Scores from study questionnaires
will be immediately calculated, copied into abstraction forms
together with other relevant study variables, and then entered
into STATA software [18]. The study database will be kept on
a server at the University of Massachusetts Medical School,
with multiple levels of password protection ensuring data
security. All statistical analyses will be performed using
STATA version 10 statistical software [18].
2.11. Statistical Analysis. Descriptive statistics will be used
to describe retention and adherence indices; a graphical
examination of the distribution of the continuous variables
will be used to assess the need for transformation and to
show patterns (e.g., whether the amount of self-reported
daily mindfulness practice shows preferential “patterns”
of practice). Correlations between duration of individual
mindfulness practice and baseline characteristics such as age,
gender, education, and severity of cardiac illness will be
evaluated using Spearman’s correlation. We will assess the
preliminary estimates of eﬀect sizes of the MBI intervention
on pre-/postintervention diﬀerences in mindfulness and
anxiety scores using multivariate linear regression models
(shown here for FFM scores): y (pre-/postintervention dif-
ference in FFM scores = β0 + β1 TX (0 control, 1 treatment)
+ β2 age + β3 gender (0,1) + β4 baseline FFM · · · + ε.
2.12. Sample Size. Our planned sample size (n = 52, 26 for
each arm) has been calculated (Table 2) using hypothetical
estimates of eﬀect size on anxiety (secondary outcome),
based on data from two studies using HADS anxiety scores
as the outcome variable in similar patients [31, 32]. Based on
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our previous experience with mindfulness-based interven-
tions in menopausal women and bone-marrow transplant
candidates, a potential loss of 20% of patients may be
expected during the study, and consequently we will need to
enroll 52 patients in order to leave 42 for the final analysis.
3. Discussion
The purpose of this study is to evaluate whether a
mindfulness-based behavioral intervention delivered over
the phone and adapted to the needs of ICD patients would
be feasible and acceptable to these individuals. Since the
proposed intervention will involve several changes from the
traditional MBSR program, the question arises of whether
such changes are legitimate. Since its inception in the early
eighties the MBSR program has been modified several times
tomeet the needs of hospitalized patients [33] or tominimize
the time commitment required [34]. Carmody et al. [35]
found no association between the number of class hours
employed in published trials of MBSR and the eﬀect sizes for
measures of psychological distress. Furthermore, diﬀerent
psychological interventions, including cognitive behavioral
therapy, [36–45] have been successfully implemented over
the phone. Given this, it seems reasonable to hypothesize
that mindfulness training could be delivered over the phone,
and, in fact, phone delivery may have an important impact
on retention: the attrition rate reported in a meta-analysis
of studies evaluating the eﬀect of telephone-administered
psychotherapy on symptoms of depression was only 7.6%.
This study presents some limitations, which for the most
part reflect its pilot nature and budgetary constraints. First,
we did not have the financial and personnel resources to
plan for the recruitment from additional clinical centers to
achieve an ethnically diverse population. For similar reasons
we will not be able to have an active control comparison
group. Under ideal conditions, a three-arm randomization to
a nurse education intervention, a mindfulness intervention,
and usual care would probably be the optimal design. A usual
care comparison group does not control for the possible
eﬀect deriving from the interaction with the instructor,
independently of the intervention administered. Second,
study assessments will occur only before and after the
intervention. Further data collection points (i.e., at six
months and one year) would provide useful information
about a possible long-term eﬀect of the intervention on
anxiety and possibly on the number of shocks. However,
this pilot study is a very preliminary exploration of the
possible eﬀects of a mindfulness-based intervention on
anxiety in cardiac patients and specifically, in ICD-implanted
patients. It seems that evidence of a short-term eﬀect is
warranted before the analysis can be carried on further.
Third, study participants will not be blinded. This is a
common limitation of behavioral interventions; however,
assessors will be blinded to patients’ treatment allocation
status and the instructors will be blinded to study outcomes.
Finally, the individual mindfulness practice will be self-
reported. With adequate funding, it would be possible to
develop techniques to track the amount of time that each
participant listens to the study CD, such as the device used by
Bauer-Wu et al. [33] or by posting each recorded session on
a dedicated intervention website and then tracking the time
that each participant is logged onto the website.
In conclusion, this project has potentially great sig-
nificance considering the prevalence of anxiety in this
population (up to 40%) [15] and the increased number of
candidates for ICD implantation due to a broadening of
ICD indications to include primary prevention of sudden
death [46]. To date, there have been no published studies
of mindfulness-based interventions in ICD patients. A
mindfulness-based intervention, adapted to this group of
patients, is relatively inexpensive and, once learned, could be
easily self-administered by the patient. If proven feasible and
eﬀective, it could positively impact the psychological well-
being and the quality of life of these patients.
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